BIO — Bio-Rad Laboratories Share News
0.000.00%
Last trade - 00:00- $9.85bn
- $9.39bn
- $2.58bn
Bio-Rad Laboratories, Inc. reports results for the quarter ended September 30 - Earnings Summary
Bio-Rad's Q3 revenue comes slightly above estimates on Clinical Diagnostics growth
Brief: Bio-Rad Q3 EBIT Margin -7.6%
Bio-Rad Laboratories, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Bio-Rad Laboratories On July 31, Initiated Restructuring Plan - SEC Filing
Bio-Rad Q2 revenue beats analyst estimates on clinical diagnostics growth
Brief: Bio-Rad Q2 Net Income USD 371.4 Million
Activist investors make bigger push for campaigns in H1, seek more M&A
U.S. STOCKS ON THE MOVE-Eli Lilly, BlackRock TCP Capital, Boston Scientific
U.S. STOCKS ON THE MOVE-Cognizant, Coursera, ServiceNow
U.S. STOCKS ON THE MOVE-Ford Motor, Intel, Hims & Hers Health
U.S. STOCKS ON THE MOVE-Macy's, Dominion Energy, Bio-Rad Laboratories
Bio‑Rad Laboratories jumps after report Elliott builds stake
Sartorius shares rise after report of Elliott investment
Press Digest: Wall Street Journal - May 18
Elliott builds big stake in life-science tools supplier Bio-Rad Labs, WSJ reports (updated)
Activist investor Elliott builds stake in life-science tools supplier Bio-Rad Laboratories, WSJ reports
Brief: Activist Elliott Investment Management Has Built A Sizable Stake In Bio-Rad Laboratories- WSJ
U.S. RESEARCH ROUNDUP- Applied Materials, NVIDIA, Thermo Fisher Scientific